Early experience with inhaled nitric oxide for the treatment of infants and children with pulmonary hypertension.

Simple item page
dc.contributor.authorEasa, David
dc.contributor.authorMurai, D T
dc.contributor.authorOka, B
dc.contributor.authorDressel, M
dc.contributor.authorVanderford, P
dc.contributor.authorPelke, S
dc.contributor.authorBalaraman, Venkataraman
dc.date.accessioned2016-10-25T23:39:36Z
dc.date.available2016-10-25T23:39:36Z
dc.date.issued1996-04
dc.description.abstractWhen nitric oxide (NO), an endogenous regulator of smooth muscle tone, is administered by inhalation, it acts as a selective pulmonary vasodilator. This report details the treatment with inhaled NO of the first 11 patients in Hawaii.
dc.identifier.issn0017-8594
dc.identifier.pubmed8935980
dc.identifier.urihttp://hdl.handle.net/10524/54117
dc.language.isoeng
dc.subject.meshAdministration, Inhalation
dc.subject.meshChild, Preschool
dc.subject.meshDose-Response Relationship, Drug
dc.subject.meshDrug Administration Schedule
dc.subject.meshFemale
dc.subject.meshHumans
dc.subject.meshHypertension, Pulmonary/drug therapy/etiology/mortality
dc.subject.meshInfant
dc.subject.meshInfant, Newborn
dc.subject.meshMale
dc.subject.meshNitric Oxide/administration & dosage
dc.subject.meshPulmonary Artery/drug effects
dc.subject.meshSurvival Rate
dc.subject.meshVasodilation/drug effects
dc.titleEarly experience with inhaled nitric oxide for the treatment of infants and children with pulmonary hypertension.
dc.typeArticle
dc.type.dcmiText
prism.number4
prism.pagerange67-9
prism.publicationnameHawaii Medical Journal
prism.volume55

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
1996-04p67-69.pdf
Size:
341.94 KB
Format:
Adobe Portable Document Format
Download

Collections

Hawaii Medical Journal Articles For 1996